Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

5
results for

"Polymerase chain reaction"

Article category

Keywords

Publication year

"Polymerase chain reaction"

Review

Viral hepatitis

Approaches to quantifying hepatitis B virus covalently closed circular DNA
Henrik Zhang, Thomas Tu
Clin Mol Hepatol 2022;28(2):135-149.
Published online October 22, 2021
DOI: https://doi.org/10.3350/cmh.2021.0283
Chronic hepatitis B is a major cause of liver disease worldwide and is currently incurable. Hepatitis B virus (HBV) covalently closed circular (ccc) DNA is a key form of the virus responsible for its persistence and is the transcriptional template for all viral transcripts. The field is focussed on methods to clear HBV cccDNA but this been limited by technical difficulties in its quantification due to: identical sequence to other forms of HBV DNA; low copy number per cell; and high resistance to denaturation by heat, leading to difficulty using polymerase chain reaction or hybridization methods for detection. A number of assays have been developed in order to overcome these hurdles either directly or detecting cccDNA levels indirectly via its transcriptional products. In this review, we summarize the approaches to cccDNA quantification that are currently used, and outline key open questions in the cccDNA biology field which remain to be answered due to the limitations of current methods.

Citations

Citations to this article as recorded by  Crossref logo
  • Editorial: High qHBsAg—is it a good or bad signal?
    Beom Kyung Kim
    Alimentary Pharmacology & Therapeutics.2024; 59(12): 1616.     CrossRef
  • Metabolic disorders and hepatitis: Insights from a Mendelian randomization study
    Ling-Bo Liang, Xiang-Ping Liu, Ting-Rui Mao, Qiao-Li Su
    World Journal of Gastrointestinal Surgery.2024; 16(6): 1775.     CrossRef
  • Detection technology and clinical applications of serum viral products of hepatitis B virus infection
    Ying Liu, Di Wu, Kui Zhang, Rongrong Ren, Yuxuan Liu, Shuya Zhang, Xuanyu Zhang, Jilin Cheng, Liping Chen, Jun Huang
    Frontiers in Cellular and Infection Microbiology.2024;[Epub]     CrossRef
  • New Approaches to Chronic Hepatitis B
    Dan L. Longo, Geoffrey Dusheiko, Kosh Agarwal, Mala K. Maini
    New England Journal of Medicine.2023; 388(1): 55.     CrossRef
  • Construction of a Lasso regression-based prediction model for development of cirrhosis in chronic hepatitis B
    Ying Li, Ke-Xing Han, Qian Su, Nan Xu, Qin-Xiu Xie, Yu-Feng Gao
    World Chinese Journal of Digestology.2023; 31(7): 282.     CrossRef
  • Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
    Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
    Clinical and Molecular Hepatology.2023; 29(2): 482.     CrossRef
  • An RNA-based system to study hepatitis B virus replication and evaluate antivirals
    Yingpu Yu, William M. Schneider, Maximilian A. Kass, Eleftherios Michailidis, Ashley Acevedo, Ana L. Pamplona Mosimann, Juliano Bordignon, Alexander Koenig, Christine M. Livingston, Hardeep van Gijzel, Yi Ni, Pradeep M. Ambrose, Catherine A. Freije, Mengy
    Science Advances.2023;[Epub]     CrossRef
  • Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors
    Phuong Thi Bich Doan, Kouki Nio, Tetsuro Shimakami, Kazuyuki Kuroki, Ying-Yi Li, Saiho Sugimoto, Hideo Takayama, Hikari Okada, Shuichi Kaneko, Masao Honda, Taro Yamashita
    Viruses.2023; 15(5): 1178.     CrossRef
  • Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
    Beom Kyung Kim, Sang Hoon Ahn
    Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
  • Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B
    Thomas Tu, Harout Ajoyan, Jacob George
    Clinics in Liver Disease.2023; 27(4): 837.     CrossRef
  • Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
    Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
    Clinical and Molecular Hepatology.2023; 29(3): 794.     CrossRef
  • cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels
    Ee Chee Ren, Nicole Ziyi Zhuo, Zhi Yi Goh, Isabelle Bonne, Benoît Malleret, Hui Ling Ko
    Biomolecules.2023; 13(10): 1438.     CrossRef
  • Hepatitis B Virus and microRNAs: A Bioinformatics Approach
    Verdiana Zulian, Giulia Fiscon, Paola Paci, Anna Rosa Garbuglia
    International Journal of Molecular Sciences.2023; 24(24): 17224.     CrossRef
  • Surrogate Markers for Hepatitis B Virus Covalently Closed Circular DNA
    Thomas Tu, Florian van Bömmel, Thomas Berg
    Seminars in Liver Disease.2022; 42(03): 327.     CrossRef
  • 12,372 View
  • 401 Download
  • 13 Web of Science
  • Crossref
Original Articles

Viral hepatitis

Multiplex polymerase chain reaction test for the diagnosis of acute viral hepatitis A
Nae-Yun Heo, Young-Suk Lim, Jihyun An, Sun-Young Ko, Heung-Bum Oh
Korean J Hepatol 2012;18(4):397-403.
Published online December 21, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.4.397
Background/Aims

The early diagnosis of acute hepatitis A (AHA) is hindered because serum IgM against hepatitis A virus (HAV) can yield false-negative results during the window period. This study evaluated the diagnostic accuracy of a polymerase chain reaction (PCR) kit for HAV RNA for the diagnosis of AHA.

Methods

Samples were collected from 136 patients with acute severe hepatitis at their admission to Asan Medical Center between June 2010 and July 2010. Samples were analyzed for serum IgM anti-HAV using an immunoassay test and for qualitative HAV RNA using the Magicplex HepaTrio PCR test kit. The diagnostic accuracies of these methods were tested on the basis of clinical and laboratory diagnoses of AHA.

Results

The concordance rate and kappa value between IgM anti-HAV and HAV RNA PCR were 88.2% and 0.707, respectively. For the diagnosis of AHA, the sensitivity and specificity of IgM anti-HAV were 90.7% and 100%, respectively, when an "equivocal" result was regarded as positive; and 79.1% and 100%, respectively, when an "equivocal" result was regarded as negative. The sensitivity and specificity of HAV RNA PCR were 81.4% and 100%, respectively. All four patients with negative IgM anti-HAV and positive HAV RNA PCR results and all four patients with equivocal IgM anti-HAV RNA and positive HAV RNA PCR results were eventually diagnosed with AHA.

Conclusions

The qualitative HAV RNA PCR test has an equivalent diagnostic accuracy for AHA compared to IgM anti-HAV and may be more sensitive during the window period.

Citations

Citations to this article as recorded by  Crossref logo
  • Hepatitis A Screening for Internationally Adopted Children From Hepatitis A Endemic Countries
    Vanessa N. Raabe, Casey Sautter, Mary Chesney, Judith K. Eckerle, Cynthia R. Howard, Chandy C. John
    Clinical Pediatrics.2014; 53(1): 31.     CrossRef
  • 10,000 View
  • 61 Download
  • Crossref
Distribution of hepatitis B virus genotypes in Korea
Ji-Hyun Cho, M.D.1,2, Kui-Hyun Yoon, M.D.1,2, Key-Earn Lee, M.D.1,2, Do-Sim Park, M.D.1,2, Young-Jin Lee, M.D.1,2, Hyung-Bae Moon, M.D.2,3, Kyoung R. Lee, M.D.5, Chang-Soo Choi, M.D.2,4, Eun-Young Cho, M.D.2,4, Haak-Cheoul Kim, M.D.2,4
Korean J Hepatol 2009;15(2):140-147.
Published online June 30, 2009
DOI: https://doi.org/10.3350/kjhep.2009.15.2.140
Backgrounds/Aims
Considering the incidence of prevailing hepatitis B virus (HBV) genotypes in neighboring nations, the predominance of genotype C in Korea is exceptional and needs to be confirmed by nationwide investigation. Methods: A total of 510 HBsAg (+) or HBeAg (+) serum samples was collected from subjects in several cities and harbors throughout the Korean peninsula for genotype (A-G)-specific multiplex PCR analysis. Another 40 serum samples from chronic HBV carriers from Iksan city were selected for sequencing of the entire HBV genome. Phylogenetic analysis was performed with 22 whole genomic sequences of Korean HBV strains enrolled in GenBank. Results: An amplicon was found in 377 specimens and genotype C occupied 98.1% (370 cases); none of the other genotypes were found. A mixed pattern of genotypes B and C was seen in seven specimens (1.9%), of which five were tested using PCR targeting the X fragment; no genotype B bands were found. With the exception of 1 case, which was subgenotype A2, whole sequences of Korean HBV strains (n=62) belonged to subgenotype C2. Conclusions: The prevailing HBV genotype in Korea is C2; the other genotypes occur only rarely. Future studies should include confirmation of the detection of genotypes other than C. (Korean J Hepatol 2009;15:140-147)

Citations

Citations to this article as recorded by  Crossref logo
  • Predictive value of HBeAg titer dynamics for HBsAg clearance in pediatric chronic hepatitis B
    Sukjin Hong, Jun Hyun Hwang, Keumoung Kim, Younghae Do, Naeun Kwak, Hyo Rim Suh, Sujin Choi, Ben Kang, Byung-Ho Choe
    Frontiers in Pediatrics.2025;[Epub]     CrossRef
  • Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
    Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
    Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
  • Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals
    Soo Young Hwang, Sung Hwan Yoo, Hye Young Chang, Sora Kim, Jung Il Lee, Kwan Sik Lee, Young Youn Cho, Kim Hyung Joon, Hyun Woong Lee
    Journal of Viral Hepatitis.2023; 30(1): 39.     CrossRef
  • Lack of geographical and ethnic distribution of Hepatitis B virus genotypes in Hainan Island, China
    Yihan Xiao, Zhigang Cui, Long Sun, Xiaojun Zhou, Lihua Li, Lixian Wu, Yunfan Quan, Xiuji Cui
    Infection, Genetics and Evolution.2023; 107: 105401.     CrossRef
  • Global prevalence and molecular characteristics of three clades within hepatitis B virus subgenotype C2: Predominance of the C2(3) clade in South Korea
    Dong Hyun Kim, Yu-Min Choi, Junghwa Jang, Bum-Joon Kim
    Frontiers in Microbiology.2023;[Epub]     CrossRef
  • Hepatitis B virus immunity prior to and after administration of a ‘booster’ dose of vaccine among health-care students at a South African university
    Nisha Makan, Ernest Song, Constance Wose Kinge, Anna Kramvis
    Vaccine: X.2023; 14: 100284.     CrossRef
  • KASL clinical practice guidelines for management of chronic hepatitis B

    Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
  • Hepatitis B virus genotypes in Brazil: Introduction and dissemination
    Jonas Michel Wolf, Daniel Simon, Vagner Ricardo Lunge
    Infection, Genetics and Evolution.2021; 93: 104936.     CrossRef
  • Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir
    Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Soo Young Park, Seung Up Kim
    Journal of Viral Hepatitis.2021; 28(1): 95.     CrossRef
  • Performance Evaluations of the Abbott Alinity m Assay in Comparison with the Abbott m2000 Assay for Hepatitis B and Hepatitis C Viruses
    Jaeeun Yoo, Beom Se Son, Eunhee Han, Gyong Gi Yu, Seungok Lee
    Laboratory Medicine and Quality Assurance.2020; 42(3): 150.     CrossRef
  • Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay
    Joonhong Park, Hanwool Cho, Seung Jun Choi, Gun Dong Lee, Sang Hyun Sin, Ji Hyeong Ryu, Hye-Sun Park, Hyeyoung Lee, Yonggoo Kim, Eun-Jee Oh
    Annals of Laboratory Medicine.2019; 39(1): 86.     CrossRef
  • Origin and dissemination of hepatitis B virus genotype C in East Asia revealed by phylodynamic analysis and historical correlates
    Serena Y. C. Lin, Brittany Rife Magalis, Marco Salemi, Hsin‐Fu Liu
    Journal of Viral Hepatitis.2019; 26(1): 145.     CrossRef
  • GWAS identifying HLA‐DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: Independent association of HLA‐DPB1*04:02 possessing rs1042169 G ‐ rs9277355 C ‐ rs9277356 A
    Soie Chung, Eun Youn Roh, Boram Park, Yunhwan Lee, Sue Shin, Jong Hyun Yoon, Eun Young Song
    Journal of Viral Hepatitis.2019; 26(11): 1318.     CrossRef
  • Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir
    Jung Hwan Yu, Young Ju Suh, Young-Joo Jin, Nae-Yun Heo, Ji Woong Jang, Chan Ran You, Hyun Young An, Jin-Woo Lee
    European Journal of Gastroenterology & Hepatology.2019; 31(7): 865.     CrossRef
  • Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
    Jung Hwan Yu, Young‐Joo Jin, Jin‐Woo Lee, Don‐Haeng Lee
    Hepatology Research.2018; 48(11): 862.     CrossRef
  • Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients
    Dae Won Jun, Sang Bong Ahn, Tae Yeob Kim, Joo Hyun Sohn, Sang Gyune Kim, Se Whan Lee, Byung Ho Kim, Dong Joon Kim, Ja Kyung Kim, Hyoung Su Kim, Seong Gyu Hwang, Won Choong Choi, Won Young Tak, Heon Ju Lee, Ki Tae Yoon, Byung Cheol Yun, Sung Wook Lee, Soon
    Chinese Medical Journal.2018; 131(14): 1645.     CrossRef
  • Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study
    Seong Hee Kang, Keunhee Kang, Yeon Jong Eun, Young Sun Lee, Tae Suk Kim, Yang Jae Yoo, Sang Jun Suh, Eileen L. Yoon, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Kwan Soo Byun
    Journal of Medical Virology.2017; 89(5): 849.     CrossRef
  • Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
    Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
    Clinical and Molecular Hepatology.2017; 23(2): 170.     CrossRef
  • Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
    Sun Young Yim, Tae Hyung Kim, Suh Sang Jun, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Hyung Joon Yim, Yoon Tae Jeen, Hoon Jai Chun, Hong Sik Lee, Soon Ho Um, Chang Duck Kim, Nam Hee Won, Ho Sang Ryu
    Gut and Liver.2017; 11(3): 417.     CrossRef
  • Analytical and clinical evaluation of the Abbott RealTime hepatitis B sequencing assay
    Hee Jae Huh, Ji-Youn Kim, Myoung-Keun Lee, Nam Yong Lee, Jong-Won Kim, Chang-Seok Ki
    Journal of Clinical Virology.2016; 85: 27.     CrossRef
  • X region mutations of hepatitis B virus related to clinical severity
    Hong Kim, Seoung-Ae Lee, Bum-Joon Kim
    World Journal of Gastroenterology.2016; 22(24): 5467.     CrossRef
  • Molecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan
    Serena Y. C. Lin, Hidenori Toyoda, Takashi Kumada, Hsin-Fu Liu, Jason Blackard
    PLOS ONE.2016; 11(6): e0157103.     CrossRef
  • Precore/core region mutations of hepatitis B virus related to clinical severity
    Hong Kim, Seoung-Ae Lee, Seung Yeon Do, Bum-Joon Kim
    World Journal of Gastroenterology.2016; 22(17): 4287.     CrossRef
  • Influence of hepatitis B virus reactivation on the recurrence of HBV‐related hepatocellular carcinoma after curative resection in patients with low viral load
    W. Sohn, Y.‐H. Paik, J. Y. Cho, J. Ma Ahn, G. S. Choi, J. M. Kim, C. H. Kwon, J. W. Joh, D. H. Sinn, G.‐Y. Gwak, M. S. Choi, J. H. Lee, K. C. Koh, S. W. Paik, B. C. Yoo
    Journal of Viral Hepatitis.2015; 22(6): 539.     CrossRef
  • Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay
    Kwang Hyun Chung, Won Kim, Byeong Gwan Kim, Ho-Young Lee, Eunhyo Jin, Yuri Cho, Ji Yeon Seo, Hwi Young Kim, Yong Jin Jung, Ji Won Kim, Ji Bong Jeong, Kook Lae Lee
    Gut and Liver.2015;[Epub]     CrossRef
  • Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
    Hyo Jin Kim, Ju-Yeon Cho, Yu Jin Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee
    The Korean Journal of Internal Medicine.2015; 30(1): 32.     CrossRef
  • Analysis of HBV genotype, drug resistant mutations, and pre‐core/basal core promoter mutations in Korean patients with acute hepatitis B
    Jong Ho Lee, Sun Pyo Hong, Eun Sun Jang, Sang Jong Park, Seong Gyu Hwang, Sook‐Kyoung Kang, Sook‐Hyang Jeong
    Journal of Medical Virology.2015; 87(6): 993.     CrossRef
  • Clinical utility of complex mutations in the core promoter and proximal precore regions of the hepatitis B virus genome
    Young Min Park
    World Journal of Hepatology.2015; 7(1): 113.     CrossRef
  • Tenofovir in the Treatment of Naïve and Refractory Chronic Hepatitis B: A Single Center Experience in Saudi Arabia
    Fahad Alsohaibani, Noura Alturaif, Ahmed Abdulshakour, Saad Alghamdi, Alfadel Alshaibani, Hamad Alashgar, Khalid Alkahtani, Ingvar Kagevi
    Saudi Journal of Gastroenterology.2015; 21(5): 295.     CrossRef
  • Genotypic Polymorphisms of Hepatitis B Virus Provide Useful Information for Estimating Geographical Origin or Place of Long‐term Residence of Unidentified Cadavers
    Hiroyuki Inoue, Hisako Motani‐Saitoh, Koichi Sakurada, Hiroshi Ikegaya, Daisuke Yajima, Sayaka Nagasawa, Hirotaro Iwase
    Journal of Forensic Sciences.2014; 59(1): 236.     CrossRef
  • Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation
    Won Sohn, Yong-Han Paik, Min Woo Lee, Hyunchul Rhim, Hyo Keun Lim, Ju Yeon Cho, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
    Scandinavian Journal of Gastroenterology.2014; 49(3): 373.     CrossRef
  • Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study
    Jin-Kyoung Oh, Hai-Rim Shin, Min Kyung Lim, Heeyoun Cho, Dong-Il Kim, Youngmee Jee, Haesun Yun, Keun-Young Yoo
    BMC Cancer.2012;[Epub]     CrossRef
  • Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients
    Young-Joo Jin, Kang Mo Kim, Dong-jun Yoo, Ju Hyun Shim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh
    Virology Journal.2012;[Epub]     CrossRef
  • Viral response at 6 months is associated with treatment outcome of adefovir add‐on therapy for lamivudine‐resistance
    Yu Jin Kim, Seung Woon Paik, Dong Hyun Sinn, Geum‐Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo
    Journal of Gastroenterology and Hepatology.2012; 27(9): 1454.     CrossRef
  • High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B
    Hee Bok Chae, Mee Jin Kim, Eui Geun Seo, Yong Hyeok Choi, Hee Seung Lee, Joung Ho Han, Soon Man Yoon, Seon Mee Park, Sei Jin Youn
    The Korean Journal of Hepatology.2012; 18(1): 75.     CrossRef
  • High HBV-DNA Titer in Surrounding Liver Rather Than in Hepatocellular Carcinoma Tissue Predisposes to Recurrence After Curative Surgical Resection
    Jong Gi Choi, Young-Hwa Chung, Jeong A. Kim, Young-Joo Jin, Won Hyung Park, Danbi Lee, Ju Hyun Shim, Yoon Seon Lee, Dong Dae Seo, Myoung Kuk Jang, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Eunsil Yu, Young Joo Lee
    Journal of Clinical Gastroenterology.2012; 46(5): 413.     CrossRef
  • Performance Evaluation of New Automated Hepatitis B Viral Markers in the Clinical Laboratory
    Yongjung Park, Duck Jin Hong, Saeam Shin, Yonggeun Cho, Hyon-Suk Kim
    American Journal of Clinical Pathology.2012; 137(5): 770.     CrossRef
  • A Novel Multiplex Real-Time PCR Assay for the Concurrent Detection of Hepatitis A, B and C Viruses in Patients with Acute Hepatitis
    Yongjung Park, Beom Seok Kim, Kyu Hun Choi, Dong Ho Shin, Mi Jung Lee, Yonggeun Cho, Hyon-Suk Kim, Jason Blackard
    PLoS ONE.2012; 7(11): e49106.     CrossRef
  • The change of the quantitative HBsAg level during the natural course of chronic hepatitis B
    Yu J. Kim, Hyun C. Cho, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Byung C. Yoo, Seung W. Paik
    Liver International.2011; 31(6): 817.     CrossRef
  • Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients
    Min-Sun Kwak, Eun-Ju Cho, Eun-Sun Jang, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee
    Digestion.2011; 84(s1): 23.     CrossRef
  • Significance of hepatitis B virus genotypes and mutations in the development of hepatocellular carcinoma in Asia
    Henry Lik‐Yuen Chan
    Journal of Gastroenterology and Hepatology.2011; 26(1): 8.     CrossRef
  • Partial Virological Response to Entecavir in Treatment-Naive Patients with Chronic Hepatitis B
    Young Eun Chon, Seung Up Kim, Chun Kyon Lee, Jeong Heo, Ja Kyung Kim, Ki Tae Yoon, Mong Cho, Kwan Sik Lee, Dong Hwan Kim, Eun Hee Choi, Jun Yong Park, Do Young Kim, Chae Yoon Chon, Kwang-Hyub Han, Sang Hoon Ahn
    Antiviral Therapy.2011; 16(4): 469.     CrossRef
  • Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids
    Tae‐Wan KIM, Mi‐Na KIM, Jae‐Woo KWON, Kyung‐Mook KIM, Sae‐Hoon KIM, Won KIM, Heung‐Woo PARK, Yoon‐Seok CHANG, Sang‐Heon CHO, Kyung‐Up MIN, You‐Young KIM
    Respirology.2010; 15(7): 1092.     CrossRef
  • 6,626 View
  • 56 Download
  • Crossref
Hepatitis B and C Virus in Hepatocellular Carcinoma
Young Soo Kim, Kwang Jae Lee, Young Soo Moon, Ki Baek Hahm, Jin Hong Kim, Sung Won Cho, Sang In Lee, Chan Sup Shim*
Korean J Hepatol 1996;2(1):61-67.
Background/aims
To evaluate the role of hepatitis B virus(HBV) and hepatitis C virus(HCV) in the development of hepatocellular carcinoma(HCC) in Korea, we investigated the status of HBV and HCV infection in Korean patients with HCC. Methods:HBV DNA and HCV DNA were detected in the scrum from 45 unseiected patients with HCC.' by polymerase chain reaction. Resolts:Among 45 patients with HCC, 31 paticnts(68.9%) were positive for serum HBsAg. HBV DNA was detected in 24(77.4%) ot 31 HBsAg-positive patients and 6(42.8%) of 14 HBsAg-negative patients. Thirty-three patients(82.2'%) were positive for HBsAg and/or HBV DNA. Among 45 patients, anti-HCV was positive in 7 patients(15.5%) by first generation enzyme-linked immunoassay(EIA) and in 11 patients(24.4%) by second generation EIA. Anti-HCV positive patients by first generation EIA were all positive for anti-HCV by second generation EIA. HCV RNA was detected in 4 of ll anti-HCV-positive patients and 4 patients of 34 anti-HCV-negative patients. Among 45 patients, tifteen patients(33.3%) were positive for anti-HCV and/or HCV RNA. HCV infection was evident for 9(24.3%) of 37 patients with HBV infection and 6(75%) of 8 patients without HBV intection. Among 45 patients with HCC, only two patients(4.5%) were all negative for HBsAg, anti-HCV, HBV DNA and HCV RNA. Condusions: These data suggest that HBV is thc main etiologic factor for HCC and HCV is considered another risk factor in some patients without evidence of HBV infection. HBV and HCV could be detected in spite of the absence of serological marker tor viral iinfection.
  • 9,684 View
  • 21 Download
Genotypes of Hepatitis B Virus on Jeju Island
Ji-Hyun Cho, M.D., Do-Shim Park, M.D., Tae-Hyeon Kim, M.D.1, Joo-Jin Yeom, M.D.1, Haak-Cheoul Kim, M.D.1, Ju-Heun Moon, M.D.2 and Jae-Sik Yang, M.D.3
Korean J Hepatol 2004;10(1):42-50.
Background/Aims
Hepatitis B virus (HBV) was classified into 8 genotypes by a sequence divergence in the entire genome designated from A to H. HBV genotypes have distinct geographic distributions. Recently, HBV genotypes have been partially found as influencing the clinical manifestation of chronic liver disease in hosts. In Korea, the distribution of HBV genotypes remains unclear. The aim of this study was to evaluate the prevalence of the HBV genotype on Jeju Island. Methods: Hepatitis B virus genotypes were evaluated among 107 hepatitis B carriers residing on Jeju Island. We used single PCR and multiplex-PCR assay with genotype-specific primer pairs for HBV genotypes A-F for the genotyping. Results: 1. Fifty nine samples (55%) were positive for HBV DNA. The positivity was different according to the pattern of HBeAg/ anti-HBe expression, as -/-; 2/3 (66.7%), -/+; 30/73 (30%), +/-; 24/28 (85.7%) and +/+; 3/3 (100%). 2. In the single primer set of genotype-specific PCR, 59 samples (100%) were detected as genotype C and 2 (3%) were also detected as genotype A and B. 3. In multiplex-PCR, 58 samples (98%) were detected as genotype C and only one (2%) as a mixed pattern of genotype B and C. 4. When the PCR products were amplified with universal sense and genotype specific anti-sense from one genotype A, one B, and 2 C, all were included in genotype C. Conclusions: These results suggest that on Jeju Island, almost all HBV genotypes are C.(Korean J Hepatol 2004;10:42-50)
  • 3,387 View
  • 16 Download